Equities Research Analysts’ New Coverage for February 5th (ALOT, AXDX, BERY, CARV, CHEK, CIZN, CPSH, CSGP, EBTC, EVBN)

Equities Research Analysts’ new coverage for Wednesday, February 5th:

StockNews.com began coverage on shares of AstroNova (NASDAQ:ALOT). The firm issued a buy rating on the stock.

StockNews.com started coverage on shares of Accelerate Diagnostics (NASDAQ:AXDX). StockNews.com issued a hold rating on the stock.

StockNews.com began coverage on shares of Berry Global Group (NYSE:BERY). StockNews.com issued a buy rating on the stock.

StockNews.com assumed coverage on shares of Carver Bancorp (NASDAQ:CARV). They issued a sell rating on the stock.

StockNews.com started coverage on shares of Check-Cap (NASDAQ:CHEK). StockNews.com issued a sell rating on the stock.

StockNews.com initiated coverage on shares of Citizens (NASDAQ:CIZN). StockNews.com issued a sell rating on the stock.

StockNews.com assumed coverage on shares of CPS Technologies (NASDAQ:CPSH). The firm issued a hold rating on the stock.

Wells Fargo & Company began coverage on shares of CoStar Group (NASDAQ:CSGP). The firm issued an underweight rating and a $65.00 target price on the stock.

StockNews.com started coverage on shares of Enterprise Bancorp (NASDAQ:EBTC). StockNews.com issued a hold rating on the stock.

StockNews.com initiated coverage on shares of Evans Bancorp (NYSE:EVBN). StockNews.com issued a hold rating on the stock.

StockNews.com began coverage on shares of FibroGen (NASDAQ:FGEN). They issued a hold rating on the stock.

StockNews.com started coverage on shares of New Concept Energy (NYSE:GBR). StockNews.com issued a sell rating on the stock.

Maxim Group assumed coverage on shares of RDE (NASDAQ:GIFT). Maxim Group issued a buy rating and a $4.00 target price on the stock.

StockNews.com began coverage on shares of Gold Resource (NYSE:GORO). StockNews.com issued a hold rating on the stock.

Raymond James assumed coverage on shares of Robinhood Markets (NASDAQ:HOOD). They issued a market perform rating on the stock.

StockNews.com started coverage on shares of Inuvo (NYSE:INUV). StockNews.com issued a hold rating on the stock.

StockNews.com began coverage on shares of Interpublic Group of Companies (NYSE:IPG). They issued a hold rating on the stock.

StockNews.com started coverage on shares of IRIDEX (NASDAQ:IRIX). StockNews.com issued a hold rating on the stock.

Lake Street Capital assumed coverage on shares of Knightscope (NASDAQ:KSCP). They issued a buy rating and a $17.00 target price on the stock.

StockNews.com began coverage on shares of Liberty TripAdvisor (NASDAQ:LTRPA). They issued a buy rating on the stock.

Bank of America Co. began coverage on shares of Intuitive Machines (NASDAQ:LUNR). The firm issued an underperform rating and a $16.00 target price on the stock.

StockNews.com began coverage on shares of Veradigm (NASDAQ:MDRX). StockNews.com issued a hold rating on the stock.

StockNews.com initiated coverage on shares of NovaBay Pharmaceuticals (NYSE:NBY). StockNews.com issued a hold rating on the stock.

StockNews.com began coverage on shares of OpGen (NASDAQ:OPGN). StockNews.com issued a sell rating on the stock.

Piper Sandler initiated coverage on shares of Opera (NASDAQ:OPRA). They issued an overweight rating and a $25.00 price target on the stock.

TD Cowen initiated coverage on shares of Palvella Therapeutics (NASDAQ:PVLA). The firm issued a buy rating and a $44.00 target price on the stock.

StockNews.com began coverage on shares of Penns Woods Bancorp (NASDAQ:PWOD). They issued a hold rating on the stock.

StockNews.com started coverage on shares of S&W Seed (NASDAQ:SANW). They issued a sell rating on the stock.

StockNews.com began coverage on shares of SenesTech (NASDAQ:SNES). The firm issued a sell rating on the stock.

StockNews.com initiated coverage on shares of The Container Store Group (NYSE:TCS). StockNews.com issued a hold rating on the stock.

StockNews.com initiated coverage on shares of Titan Pharmaceuticals (NASDAQ:TTNP). They issued a sell rating on the stock.

StockNews.com began coverage on shares of Vanda Pharmaceuticals (NASDAQ:VNDA). StockNews.com issued a hold rating on the stock.